Growing number of incident pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in Latvia: a shifting epidemiological landscape? Data from a national pulmonary hypertension registry

Published: 29 September 2018
Author(s): Kristaps Sablinskis, Matiss Sablinskis, Aivars Lejnieks, Andris Skride
Section: Letter to the Editor

Pulmonary hypertension (PH) is a complex, progressing and debilitating pulmonary vascular disease associated with poor prognosis. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are two distinct subtypes of PH with different pathophysiologic mechanisms and treatment strategies [1]⁠.